Spatial genomics & transcriptomics involves studying gene expressions at a single-cell resolution within tissues to identify cell types and states. It aids in understanding disease biology and drug response at multiple scales.
The global Spatial Genomics Transcriptomics Market is estimated to be valued at US$ 262.7 Mn or Mn in 2023 and is expected to exhibit a CAGR of 13.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Rising focus on precision medicine is driving the demand for spatial genomics & transcriptomics. Spatially resolved transcriptomic analysis provides cell type specific transcriptomic profiles within tissues which help in identifying novel disease subtypes and biomarkers. Growing R&D investments by pharmaceutical and biotechnology companies in spatial genomics tools for drug discovery and development is also fueling market growth. Furthermore, development of new spatial genomics platforms with improved throughput, resolution, and cost-effectiveness is expected to create lucrative opportunities over the forecast period.
Strength: Spatial genomics transcriptomics allows mapping gene expression at sub-cellular resolution across tissues and correlated it with spatial information. This helps gain in-depth understanding of complex biological systems at unprecedented resolutions.
Weakness: Spatial genomics transcriptomics techniques require expensive instruments, reagents and computational resources that are prohibitive for small research groups and private labs. Sample preparation is complex and time consuming.
Opportunity: Growing applications of spatial genomics transcriptomics in drug discovery, cancer research, neuroscience, and developmental biology is driving demand. Advancements in spatial data processing and analytical software is also creating opportunities.
Threats: Stiff competition among existing players to gain market share poses pricing pressure. Slow adoption rate by non-specialized labs and institutions is also a challenge for high growth. Dependence on a few vendors for instruments and reagents increases supply chain risk.
The global spatial genomics transcriptomics market is expected to witness high growth at a CAGR of 13% over the forecast period, driven by increasing focus on spatial tissue profiling techniques for advanced disease research.
Regional analysis: North America dominates the market currently due to presence of major players and availability of funding for spatial omics research. Asia Pacific is expected to witness fastest growth supported by increasing R&D investments in China, South Korea and India.
Key players analysis: Major players like 10x Genomics, NanoString Technologies, Illumina, Fluidigm Corporation, and PerkinElmer offer instruments, reagents and software for spatial gene expression analysis. New entrants like Spatial Transcriptomics, Dovetail Genomics, S2 Genomics are bringing newer technologies like in-situ sequencing for tissue profiling. Partnerships and acquisitions are common in this space to expand capabilities.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it